October 26-27 2020 Boston, MA
Kate has always been driven to make a difference in patients’ lives, from her early academic research at Oxford and Harvard Universities, to leading drug discovery teams and organisations in industry. Prior to joining Healx, Kate was Corporate VP at Charles River Discovery, leading a team of over 400 drug discovery scientists in three countries. The client base was worldwide and under her leadership the organization delivered on average 3-4 preclinical drug candidates per year for its partners. Her 25+ years’ industry experience includes senior leadership positions at Cambridge Antibody Technology as Director of Discovery Biology and Roche as Head of Inflammatory Diseases.